Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07357818 · ClinicalTrials.gov registry record · NA

Effects of Caffeinated Beverages on Well-being

A NA study of Healthy and Caffeine, sponsored by Guayaki Sustainable Rainforest Products.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT07357818 is a NA study of Healthy and Caffeine that is actively recruiting participants, run by Guayaki Sustainable Rainforest Products. The registered enrollment target is 150 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07357818, a NA study of Healthy and Caffeine, is actively recruiting participants, sponsored by Guayaki Sustainable Rainforest Products.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.

Interventions

  • OTHER Participants' typical caffeinated beverage
  • OTHER Test caffeinated beverage

Study Locations (1)

California

  • Alethios, Inc. - San Francisco

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-11-03
Est. Completion 2026-04
Phase NA

What the Registry Record Tells You About NCT07357818

The ClinicalTrials.gov registry entry for NCT07357818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (77% lower). The listed sponsor is Guayaki Sustainable Rainforest Products, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Participants' typical caffeinated beverage is the first listed.

NCT07357818 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07357818 about?

NCT07357818 is a clinical study titled "Effects of Caffeinated Beverages on Well-being". This study will evaluate post-beverage subjective caffeine responses and physiological responses to caffeinated beverages in generally healthy adults.

What is the current status of trial NCT07357818?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-11-03. Estimated completion is 2026-04.

What conditions does trial NCT07357818 study?

This clinical trial studies the following conditions: Healthy, Caffeine, Beverage Intake.

What interventions are being tested in trial NCT07357818?

The interventions under investigation include: Participants' typical caffeinated beverage (OTHER), Test caffeinated beverage (OTHER).

Who is sponsoring clinical trial NCT07357818?

This trial is sponsored by Guayaki Sustainable Rainforest Products, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07357818 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.